← Eichor
Study identifier: NCT05460611 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia

Condition: Scarring Alopecia · Androgenetic Alopecia  ·  Sponsor: Montefiore Medical Center

PhaseNA
Planned participants10
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersYes

About this study

Single-center, open-label, baseline-controlled, pilot study evaluating the use of a Nonablative 1470 nm laser for the treatment of androgenetic alopecia and scarring alopecia.

This description comes directly from the study's public registry record.

Talk to the study team

Anika Jallorina, BS  ·  618-704-8716  ·  ajallorina@montefiore.org

Always discuss trial participation with your own doctor first.

Locations (1)

Montefiore Einstein Advanced CareElmsford, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05460611